img

Global Lymphedema Diagnostics Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Lymphedema Diagnostics Market Research Report 2024

According to MRAResearch’s new survey, global Lymphedema Diagnostics market is projected to reach US$ 39 million in 2033, increasing from US$ 27 million in 2022, with the CAGR of 5.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Lymphedema Diagnostics market research.
Key companies engaged in the Lymphedema Diagnostics industry include GE Healthcare, Siemens Healthineers (A Subsidiary of Siemens Group), Philips, Canon, Inc., Shimadzu Corporation, Stryker Corporation, Fluoptics, United Imaging Healthcare Co., Ltd. and Hitachi, Ltd., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Lymphedema Diagnostics were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Lymphedema Diagnostics market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Lymphedema Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


GE Healthcare
Siemens Healthineers (A Subsidiary of Siemens Group)
Philips
Canon, Inc.
Shimadzu Corporation
Stryker Corporation
Fluoptics
United Imaging Healthcare Co., Ltd.
Hitachi, Ltd.
Esaote SPA
Neusoft Corporation
Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.)
Mitaka Usa, Inc.
Curadel, LLC
Impedimed Limited
Segment by Type
Lymphoscintigraphy
Magnetic Resonance Imaging
Ultrasound Imaging
Computed Tomography
X-Ray Lymphography
Bioimpedance Analysis
Near-Infrared Fluorescence Imaging

Segment by Application


Cancer
Inflammatory Diseases
Cardiovascular Disease
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Lymphedema Diagnostics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lymphedema Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Lymphoscintigraphy
1.2.3 Magnetic Resonance Imaging
1.2.4 Ultrasound Imaging
1.2.5 Computed Tomography
1.2.6 X-Ray Lymphography
1.2.7 Bioimpedance Analysis
1.2.8 Near-Infrared Fluorescence Imaging
1.3 Market by Application
1.3.1 Global Lymphedema Diagnostics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Cancer
1.3.3 Inflammatory Diseases
1.3.4 Cardiovascular Disease
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lymphedema Diagnostics Market Perspective (2018-2033)
2.2 Lymphedema Diagnostics Growth Trends by Region
2.2.1 Global Lymphedema Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Lymphedema Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Lymphedema Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 Lymphedema Diagnostics Market Dynamics
2.3.1 Lymphedema Diagnostics Industry Trends
2.3.2 Lymphedema Diagnostics Market Drivers
2.3.3 Lymphedema Diagnostics Market Challenges
2.3.4 Lymphedema Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lymphedema Diagnostics Players by Revenue
3.1.1 Global Top Lymphedema Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Lymphedema Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Lymphedema Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lymphedema Diagnostics Revenue
3.4 Global Lymphedema Diagnostics Market Concentration Ratio
3.4.1 Global Lymphedema Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lymphedema Diagnostics Revenue in 2022
3.5 Lymphedema Diagnostics Key Players Head office and Area Served
3.6 Key Players Lymphedema Diagnostics Product Solution and Service
3.7 Date of Enter into Lymphedema Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lymphedema Diagnostics Breakdown Data by Type
4.1 Global Lymphedema Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Lymphedema Diagnostics Forecasted Market Size by Type (2024-2033)
5 Lymphedema Diagnostics Breakdown Data by Application
5.1 Global Lymphedema Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Lymphedema Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Lymphedema Diagnostics Market Size (2018-2033)
6.2 North America Lymphedema Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Lymphedema Diagnostics Market Size by Country (2018-2023)
6.4 North America Lymphedema Diagnostics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lymphedema Diagnostics Market Size (2018-2033)
7.2 Europe Lymphedema Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Lymphedema Diagnostics Market Size by Country (2018-2023)
7.4 Europe Lymphedema Diagnostics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lymphedema Diagnostics Market Size (2018-2033)
8.2 Asia-Pacific Lymphedema Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Lymphedema Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Lymphedema Diagnostics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lymphedema Diagnostics Market Size (2018-2033)
9.2 Latin America Lymphedema Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Lymphedema Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Lymphedema Diagnostics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lymphedema Diagnostics Market Size (2018-2033)
10.2 Middle East & Africa Lymphedema Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Lymphedema Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Lymphedema Diagnostics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Detail
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Lymphedema Diagnostics Introduction
11.1.4 GE Healthcare Revenue in Lymphedema Diagnostics Business (2018-2023)
11.1.5 GE Healthcare Recent Development
11.2 Siemens Healthineers (A Subsidiary of Siemens Group)
11.2.1 Siemens Healthineers (A Subsidiary of Siemens Group) Company Detail
11.2.2 Siemens Healthineers (A Subsidiary of Siemens Group) Business Overview
11.2.3 Siemens Healthineers (A Subsidiary of Siemens Group) Lymphedema Diagnostics Introduction
11.2.4 Siemens Healthineers (A Subsidiary of Siemens Group) Revenue in Lymphedema Diagnostics Business (2018-2023)
11.2.5 Siemens Healthineers (A Subsidiary of Siemens Group) Recent Development
11.3 Philips
11.3.1 Philips Company Detail
11.3.2 Philips Business Overview
11.3.3 Philips Lymphedema Diagnostics Introduction
11.3.4 Philips Revenue in Lymphedema Diagnostics Business (2018-2023)
11.3.5 Philips Recent Development
11.4 Canon, Inc.
11.4.1 Canon, Inc. Company Detail
11.4.2 Canon, Inc. Business Overview
11.4.3 Canon, Inc. Lymphedema Diagnostics Introduction
11.4.4 Canon, Inc. Revenue in Lymphedema Diagnostics Business (2018-2023)
11.4.5 Canon, Inc. Recent Development
11.5 Shimadzu Corporation
11.5.1 Shimadzu Corporation Company Detail
11.5.2 Shimadzu Corporation Business Overview
11.5.3 Shimadzu Corporation Lymphedema Diagnostics Introduction
11.5.4 Shimadzu Corporation Revenue in Lymphedema Diagnostics Business (2018-2023)
11.5.5 Shimadzu Corporation Recent Development
11.6 Stryker Corporation
11.6.1 Stryker Corporation Company Detail
11.6.2 Stryker Corporation Business Overview
11.6.3 Stryker Corporation Lymphedema Diagnostics Introduction
11.6.4 Stryker Corporation Revenue in Lymphedema Diagnostics Business (2018-2023)
11.6.5 Stryker Corporation Recent Development
11.7 Fluoptics
11.7.1 Fluoptics Company Detail
11.7.2 Fluoptics Business Overview
11.7.3 Fluoptics Lymphedema Diagnostics Introduction
11.7.4 Fluoptics Revenue in Lymphedema Diagnostics Business (2018-2023)
11.7.5 Fluoptics Recent Development
11.8 United Imaging Healthcare Co., Ltd.
11.8.1 United Imaging Healthcare Co., Ltd. Company Detail
11.8.2 United Imaging Healthcare Co., Ltd. Business Overview
11.8.3 United Imaging Healthcare Co., Ltd. Lymphedema Diagnostics Introduction
11.8.4 United Imaging Healthcare Co., Ltd. Revenue in Lymphedema Diagnostics Business (2018-2023)
11.8.5 United Imaging Healthcare Co., Ltd. Recent Development
11.9 Hitachi, Ltd.
11.9.1 Hitachi, Ltd. Company Detail
11.9.2 Hitachi, Ltd. Business Overview
11.9.3 Hitachi, Ltd. Lymphedema Diagnostics Introduction
11.9.4 Hitachi, Ltd. Revenue in Lymphedema Diagnostics Business (2018-2023)
11.9.5 Hitachi, Ltd. Recent Development
11.10 Esaote SPA
11.10.1 Esaote SPA Company Detail
11.10.2 Esaote SPA Business Overview
11.10.3 Esaote SPA Lymphedema Diagnostics Introduction
11.10.4 Esaote SPA Revenue in Lymphedema Diagnostics Business (2018-2023)
11.10.5 Esaote SPA Recent Development
11.11 Neusoft Corporation
11.11.1 Neusoft Corporation Company Detail
11.11.2 Neusoft Corporation Business Overview
11.11.3 Neusoft Corporation Lymphedema Diagnostics Introduction
11.11.4 Neusoft Corporation Revenue in Lymphedema Diagnostics Business (2018-2023)
11.11.5 Neusoft Corporation Recent Development
11.12 Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.)
11.12.1 Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Company Detail
11.12.2 Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Business Overview
11.12.3 Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Lymphedema Diagnostics Introduction
11.12.4 Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Revenue in Lymphedema Diagnostics Business (2018-2023)
11.12.5 Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Recent Development
11.13 Mitaka Usa, Inc.
11.13.1 Mitaka Usa, Inc. Company Detail
11.13.2 Mitaka Usa, Inc. Business Overview
11.13.3 Mitaka Usa, Inc. Lymphedema Diagnostics Introduction
11.13.4 Mitaka Usa, Inc. Revenue in Lymphedema Diagnostics Business (2018-2023)
11.13.5 Mitaka Usa, Inc. Recent Development
11.14 Curadel, LLC
11.14.1 Curadel, LLC Company Detail
11.14.2 Curadel, LLC Business Overview
11.14.3 Curadel, LLC Lymphedema Diagnostics Introduction
11.14.4 Curadel, LLC Revenue in Lymphedema Diagnostics Business (2018-2023)
11.14.5 Curadel, LLC Recent Development
11.15 Impedimed Limited
11.15.1 Impedimed Limited Company Detail
11.15.2 Impedimed Limited Business Overview
11.15.3 Impedimed Limited Lymphedema Diagnostics Introduction
11.15.4 Impedimed Limited Revenue in Lymphedema Diagnostics Business (2018-2023)
11.15.5 Impedimed Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Lymphedema Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Lymphoscintigraphy
Table 3. Key Players of Magnetic Resonance Imaging
Table 4. Key Players of Ultrasound Imaging
Table 5. Key Players of Computed Tomography
Table 6. Key Players of X-Ray Lymphography
Table 7. Key Players of Bioimpedance Analysis
Table 8. Key Players of Near-Infrared Fluorescence Imaging
Table 9. Global Lymphedema Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Lymphedema Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global Lymphedema Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Lymphedema Diagnostics Market Share by Region (2018-2023)
Table 13. Global Lymphedema Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 14. Global Lymphedema Diagnostics Market Share by Region (2024-2033)
Table 15. Lymphedema Diagnostics Market Trends
Table 16. Lymphedema Diagnostics Market Drivers
Table 17. Lymphedema Diagnostics Market Challenges
Table 18. Lymphedema Diagnostics Market Restraints
Table 19. Global Lymphedema Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Lymphedema Diagnostics Market Share by Players (2018-2023)
Table 21. Global Top Lymphedema Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lymphedema Diagnostics as of 2022)
Table 22. Ranking of Global Top Lymphedema Diagnostics Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by Lymphedema Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Lymphedema Diagnostics Product Solution and Service
Table 26. Date of Enter into Lymphedema Diagnostics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Lymphedema Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Lymphedema Diagnostics Revenue Market Share by Type (2018-2023)
Table 30. Global Lymphedema Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 31. Global Lymphedema Diagnostics Revenue Market Share by Type (2024-2033)
Table 32. Global Lymphedema Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Lymphedema Diagnostics Revenue Market Share by Application (2018-2023)
Table 34. Global Lymphedema Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 35. Global Lymphedema Diagnostics Revenue Market Share by Application (2024-2033)
Table 36. North America Lymphedema Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Lymphedema Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Lymphedema Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Lymphedema Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 40. Europe Lymphedema Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 41. Europe Lymphedema Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 42. Asia-Pacific Lymphedema Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 43. Asia-Pacific Lymphedema Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 44. Asia-Pacific Lymphedema Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 45. Latin America Lymphedema Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Latin America Lymphedema Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 47. Latin America Lymphedema Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 48. Middle East & Africa Lymphedema Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. Middle East & Africa Lymphedema Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 50. Middle East & Africa Lymphedema Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 51. GE Healthcare Company Detail
Table 52. GE Healthcare Business Overview
Table 53. GE Healthcare Lymphedema Diagnostics Product
Table 54. GE Healthcare Revenue in Lymphedema Diagnostics Business (2018-2023) & (US$ Million)
Table 55. GE Healthcare Recent Development
Table 56. Siemens Healthineers (A Subsidiary of Siemens Group) Company Detail
Table 57. Siemens Healthineers (A Subsidiary of Siemens Group) Business Overview
Table 58. Siemens Healthineers (A Subsidiary of Siemens Group) Lymphedema Diagnostics Product
Table 59. Siemens Healthineers (A Subsidiary of Siemens Group) Revenue in Lymphedema Diagnostics Business (2018-2023) & (US$ Million)
Table 60. Siemens Healthineers (A Subsidiary of Siemens Group) Recent Development
Table 61. Philips Company Detail
Table 62. Philips Business Overview
Table 63. Philips Lymphedema Diagnostics Product
Table 64. Philips Revenue in Lymphedema Diagnostics Business (2018-2023) & (US$ Million)
Table 65. Philips Recent Development
Table 66. Canon, Inc. Company Detail
Table 67. Canon, Inc. Business Overview
Table 68. Canon, Inc. Lymphedema Diagnostics Product
Table 69. Canon, Inc. Revenue in Lymphedema Diagnostics Business (2018-2023) & (US$ Million)
Table 70. Canon, Inc. Recent Development
Table 71. Shimadzu Corporation Company Detail
Table 72. Shimadzu Corporation Business Overview
Table 73. Shimadzu Corporation Lymphedema Diagnostics Product
Table 74. Shimadzu Corporation Revenue in Lymphedema Diagnostics Business (2018-2023) & (US$ Million)
Table 75. Shimadzu Corporation Recent Development
Table 76. Stryker Corporation Company Detail
Table 77. Stryker Corporation Business Overview
Table 78. Stryker Corporation Lymphedema Diagnostics Product
Table 79. Stryker Corporation Revenue in Lymphedema Diagnostics Business (2018-2023) & (US$ Million)
Table 80. Stryker Corporation Recent Development
Table 81. Fluoptics Company Detail
Table 82. Fluoptics Business Overview
Table 83. Fluoptics Lymphedema Diagnostics Product
Table 84. Fluoptics Revenue in Lymphedema Diagnostics Business (2018-2023) & (US$ Million)
Table 85. Fluoptics Recent Development
Table 86. United Imaging Healthcare Co., Ltd. Company Detail
Table 87. United Imaging Healthcare Co., Ltd. Business Overview
Table 88. United Imaging Healthcare Co., Ltd. Lymphedema Diagnostics Product
Table 89. United Imaging Healthcare Co., Ltd. Revenue in Lymphedema Diagnostics Business (2018-2023) & (US$ Million)
Table 90. United Imaging Healthcare Co., Ltd. Recent Development
Table 91. Hitachi, Ltd. Company Detail
Table 92. Hitachi, Ltd. Business Overview
Table 93. Hitachi, Ltd. Lymphedema Diagnostics Product
Table 94. Hitachi, Ltd. Revenue in Lymphedema Diagnostics Business (2018-2023) & (US$ Million)
Table 95. Hitachi, Ltd. Recent Development
Table 96. Esaote SPA Company Detail
Table 97. Esaote SPA Business Overview
Table 98. Esaote SPA Lymphedema Diagnostics Product
Table 99. Esaote SPA Revenue in Lymphedema Diagnostics Business (2018-2023) & (US$ Million)
Table 100. Esaote SPA Recent Development
Table 101. Neusoft Corporation Company Detail
Table 102. Neusoft Corporation Business Overview
Table 103. Neusoft Corporation Lymphedema Diagnostics Product
Table 104. Neusoft Corporation Revenue in Lymphedema Diagnostics Business (2018-2023) & (US$ Million)
Table 105. Neusoft Corporation Recent Development
Table 106. Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Company Detail
Table 107. Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Business Overview
Table 108. Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Lymphedema Diagnostics Product
Table 109. Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Revenue in Lymphedema Diagnostics Business (2018-2023) & (US$ Million)
Table 110. Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Recent Development
Table 111. Mitaka Usa, Inc. Company Detail
Table 112. Mitaka Usa, Inc. Business Overview
Table 113. Mitaka Usa, Inc. Lymphedema Diagnostics Product
Table 114. Mitaka Usa, Inc. Revenue in Lymphedema Diagnostics Business (2018-2023) & (US$ Million)
Table 115. Mitaka Usa, Inc. Recent Development
Table 116. Curadel, LLC Company Detail
Table 117. Curadel, LLC Business Overview
Table 118. Curadel, LLC Lymphedema Diagnostics Product
Table 119. Curadel, LLC Revenue in Lymphedema Diagnostics Business (2018-2023) & (US$ Million)
Table 120. Curadel, LLC Recent Development
Table 121. Impedimed Limited Company Detail
Table 122. Impedimed Limited Business Overview
Table 123. Impedimed Limited Lymphedema Diagnostics Product
Table 124. Impedimed Limited Revenue in Lymphedema Diagnostics Business (2018-2023) & (US$ Million)
Table 125. Impedimed Limited Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lymphedema Diagnostics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Lymphedema Diagnostics Market Share by Type: 2022 VS 2033
Figure 3. Lymphoscintigraphy Features
Figure 4. Magnetic Resonance Imaging Features
Figure 5. Ultrasound Imaging Features
Figure 6. Computed Tomography Features
Figure 7. X-Ray Lymphography Features
Figure 8. Bioimpedance Analysis Features
Figure 9. Near-Infrared Fluorescence Imaging Features
Figure 10. Global Lymphedema Diagnostics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 11. Global Lymphedema Diagnostics Market Share by Application: 2022 VS 2033
Figure 12. Cancer Case Studies
Figure 13. Inflammatory Diseases Case Studies
Figure 14. Cardiovascular Disease Case Studies
Figure 15. Other Case Studies
Figure 16. Lymphedema Diagnostics Report Years Considered
Figure 17. Global Lymphedema Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 18. Global Lymphedema Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 19. Global Lymphedema Diagnostics Market Share by Region: 2022 VS 2033
Figure 20. Global Lymphedema Diagnostics Market Share by Players in 2022
Figure 21. Global Top Lymphedema Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lymphedema Diagnostics as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Lymphedema Diagnostics Revenue in 2022
Figure 23. North America Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. North America Lymphedema Diagnostics Market Share by Country (2018-2033)
Figure 25. United States Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe Lymphedema Diagnostics Market Share by Country (2018-2033)
Figure 29. Germany Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Asia-Pacific Lymphedema Diagnostics Market Share by Region (2018-2033)
Figure 37. China Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Japan Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. South Korea Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Southeast Asia Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. India Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Australia Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Latin America Lymphedema Diagnostics Market Share by Country (2018-2033)
Figure 45. Mexico Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Brazil Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East & Africa Lymphedema Diagnostics Market Share by Country (2018-2033)
Figure 49. Turkey Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Saudi Arabia Lymphedema Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. GE Healthcare Revenue Growth Rate in Lymphedema Diagnostics Business (2018-2023)
Figure 52. Siemens Healthineers (A Subsidiary of Siemens Group) Revenue Growth Rate in Lymphedema Diagnostics Business (2018-2023)
Figure 53. Philips Revenue Growth Rate in Lymphedema Diagnostics Business (2018-2023)
Figure 54. Canon, Inc. Revenue Growth Rate in Lymphedema Diagnostics Business (2018-2023)
Figure 55. Shimadzu Corporation Revenue Growth Rate in Lymphedema Diagnostics Business (2018-2023)
Figure 56. Stryker Corporation Revenue Growth Rate in Lymphedema Diagnostics Business (2018-2023)
Figure 57. Fluoptics Revenue Growth Rate in Lymphedema Diagnostics Business (2018-2023)
Figure 58. United Imaging Healthcare Co., Ltd. Revenue Growth Rate in Lymphedema Diagnostics Business (2018-2023)
Figure 59. Hitachi, Ltd. Revenue Growth Rate in Lymphedema Diagnostics Business (2018-2023)
Figure 60. Esaote SPA Revenue Growth Rate in Lymphedema Diagnostics Business (2018-2023)
Figure 61. Neusoft Corporation Revenue Growth Rate in Lymphedema Diagnostics Business (2018-2023)
Figure 62. Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Revenue Growth Rate in Lymphedema Diagnostics Business (2018-2023)
Figure 63. Mitaka Usa, Inc. Revenue Growth Rate in Lymphedema Diagnostics Business (2018-2023)
Figure 64. Curadel, LLC Revenue Growth Rate in Lymphedema Diagnostics Business (2018-2023)
Figure 65. Impedimed Limited Revenue Growth Rate in Lymphedema Diagnostics Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed